Breaking News, Collaborations & Alliances

Croda, Botanical Solution Partner on Sustainable Vaccine Adjuvant QS-21

The two organizations share expertise to bring to market QS-21 from Quillaja saponaria plant cell culture.

Croda Pharma and Botanical Solution Inc. (BSI) entered into a strategic collaboration agreement to support the sustainable sourcing of pharmaceutical grade adjuvant QS-21, a potent component of adjuvant systems. QS-21 is used in several innovative vaccines against diseases such as shingles, malaria and RSV, plus promising new vaccine and immunotherapy treatments such as cancer. This partnership sees the two organizations share expertise to bring to market QS-21 from Quillaja saponaria plant cel...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters